295 related articles for article (PubMed ID: 25476248)
1. Increased constitutive αSMA and Smad2/3 expression in idiopathic pulmonary fibrosis myofibroblasts is KCa3.1-dependent.
Roach KM; Wulff H; Feghali-Bostwick C; Amrani Y; Bradding P
Respir Res; 2014 Dec; 15(1):155. PubMed ID: 25476248
[TBL] [Abstract][Full Text] [Related]
2. Human lung myofibroblast TGFβ1-dependent Smad2/3 signalling is Ca(2+)-dependent and regulated by KCa3.1 K(+) channels.
Roach KM; Feghali-Bostwick C; Wulff H; Amrani Y; Bradding P
Fibrogenesis Tissue Repair; 2015; 8():5. PubMed ID: 25829947
[TBL] [Abstract][Full Text] [Related]
3. Lipoxin A4 Attenuates Constitutive and TGF-β1-Dependent Profibrotic Activity in Human Lung Myofibroblasts.
Roach KM; Feghali-Bostwick CA; Amrani Y; Bradding P
J Immunol; 2015 Sep; 195(6):2852-60. PubMed ID: 26276873
[TBL] [Abstract][Full Text] [Related]
4. The K+ channel KCa3.1 as a novel target for idiopathic pulmonary fibrosis.
Roach KM; Duffy SM; Coward W; Feghali-Bostwick C; Wulff H; Bradding P
PLoS One; 2013; 8(12):e85244. PubMed ID: 24392001
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-27a-3p Is a Negative Regulator of Lung Fibrosis by Targeting Myofibroblast Differentiation.
Cui H; Banerjee S; Xie N; Ge J; Liu RM; Matalon S; Thannickal VJ; Liu G
Am J Respir Cell Mol Biol; 2016 Jun; 54(6):843-52. PubMed ID: 26600197
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the K
Organ L; Bacci B; Koumoundouros E; Kimpton WG; Samuel CS; Nowell CJ; Bradding P; Roach KM; Westall G; Jaffar J; Snibson KJ
Am J Respir Cell Mol Biol; 2017 Apr; 56(4):539-550. PubMed ID: 28060543
[TBL] [Abstract][Full Text] [Related]
7. The KCa3.1 blocker TRAM-34 inhibits proliferation of fibroblasts in paraquat-induced pulmonary fibrosis.
Xie H; Lu J; Zhu Y; Meng X; Wang R
Toxicol Lett; 2018 Oct; 295():408-415. PubMed ID: 30036685
[TBL] [Abstract][Full Text] [Related]
8. A model of human lung fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis.
Roach KM; Sutcliffe A; Matthews L; Elliott G; Newby C; Amrani Y; Bradding P
Sci Rep; 2018 Jan; 8(1):342. PubMed ID: 29321510
[TBL] [Abstract][Full Text] [Related]
9. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
[TBL] [Abstract][Full Text] [Related]
10. Blockade of KCa3.1: A novel target to treat TGF-β1 induced conjunctival fibrosis.
Anumanthan G; Wilson PJ; Tripathi R; Hesemann NP; Mohan RR
Exp Eye Res; 2018 Feb; 167():140-144. PubMed ID: 29242028
[TBL] [Abstract][Full Text] [Related]
11. KCa3.1 ion channel: A novel therapeutic target for corneal fibrosis.
Anumanthan G; Gupta S; Fink MK; Hesemann NP; Bowles DK; McDaniel LM; Muhammad M; Mohan RR
PLoS One; 2018; 13(3):e0192145. PubMed ID: 29554088
[TBL] [Abstract][Full Text] [Related]
12. Lung myofibroblasts are characterized by down-regulated cyclooxygenase-2 and its main metabolite, prostaglandin E2.
Gabasa M; Royo D; Molina-Molina M; Roca-Ferrer J; Pujols L; Picado C; Xaubet A; Pereda J
PLoS One; 2013; 8(6):e65445. PubMed ID: 23755232
[TBL] [Abstract][Full Text] [Related]
13. Novel differences in gene expression and functional capabilities of myofibroblast populations in idiopathic pulmonary fibrosis.
Walsh SM; Worrell JC; Fabre A; Hinz B; Kane R; Keane MP
Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L697-L710. PubMed ID: 30091381
[TBL] [Abstract][Full Text] [Related]
14. NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFbeta1-induced fibroblast differentiation into myofibroblasts.
Amara N; Goven D; Prost F; Muloway R; Crestani B; Boczkowski J
Thorax; 2010 Aug; 65(8):733-8. PubMed ID: 20685750
[TBL] [Abstract][Full Text] [Related]
15. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
[TBL] [Abstract][Full Text] [Related]
16. The Role of KCNMB1 and BK Channels in Myofibroblast Differentiation and Pulmonary Fibrosis.
Scruggs AM; Grabauskas G; Huang SK
Am J Respir Cell Mol Biol; 2020 Feb; 62(2):191-203. PubMed ID: 31486669
[TBL] [Abstract][Full Text] [Related]
17. Human antigen R promotes lung fibroblast differentiation to myofibroblasts and increases extracellular matrix production.
Al-Habeeb F; Aloufi N; Traboulsi H; Liu X; Nair P; Haston C; Azuelos I; Huang SK; White ES; Gallouzi IE; Di Marco S; Eidelman DH; Baglole CJ
J Cell Physiol; 2021 Oct; 236(10):6836-6851. PubMed ID: 33855709
[TBL] [Abstract][Full Text] [Related]
18. Transglutaminase 2: a novel therapeutic target for idiopathic pulmonary fibrosis using selective small molecule inhibitors.
Fell S; Wang Z; Blanchard A; Nanthakumar C; Griffin M
Amino Acids; 2021 Feb; 53(2):205-217. PubMed ID: 33474654
[TBL] [Abstract][Full Text] [Related]
19. YAP and TAZ are distinct effectors of corneal myofibroblast transformation.
Muppala S; Raghunathan VK; Jalilian I; Thomasy S; Murphy CJ
Exp Eye Res; 2019 Mar; 180():102-109. PubMed ID: 30578787
[TBL] [Abstract][Full Text] [Related]
20. Sirtuin 6 inhibits myofibroblast differentiation via inactivating transforming growth factor-β1/Smad2 and nuclear factor-κB signaling pathways in human fetal lung fibroblasts.
Zhang Q; Tu W; Tian K; Han L; Wang Q; Chen P; Zhou X
J Cell Biochem; 2019 Jan; 120(1):93-104. PubMed ID: 30230565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
